Glasensor
About Us
Supervisor: Prof. Julien Reboud
Glasensor has developed a point-of-care biosensor to quantify Adalimumab in human plasma. The biosensor uses heat as an innovative single technology for both the principle technology formolecular recognition and a flow actuation mechanism.
Statistics
- Correlation Scatter
- Dose Response
- Time To Result
- Sample Volume
Sponsors
Contact info
For more information, please feel free to contact the team by email at [email protected] or follow us on Instagram
@glasensor.
Glasensor would like to thank BioRad for their expertise and assistance throughout the development of the biosensor.